203 related articles for article (PubMed ID: 16823039)
21. Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles.
de Alba E; Weiler S; Tjandra N
Biochemistry; 2003 Dec; 42(50):14729-40. PubMed ID: 14674747
[TBL] [Abstract][Full Text] [Related]
22. Conformational dynamics of a lipid-interacting protein: MD simulations of saposin B.
Stokeley D; Bemporad D; Gavaghan D; Sansom MS
Biochemistry; 2007 Nov; 46(47):13573-80. PubMed ID: 17983243
[TBL] [Abstract][Full Text] [Related]
23. Structural and membrane-binding properties of saposin D.
Tatti M; Salvioli R; Ciaffoni F; Pucci P; Andolfo A; Amoresano A; Vaccaro AM
Eur J Biochem; 1999 Jul; 263(2):486-94. PubMed ID: 10406958
[TBL] [Abstract][Full Text] [Related]
24. Saposins and their interaction with lipids.
Vaccaro AM; Salvioli R; Tatti M; Ciaffoni F
Neurochem Res; 1999 Feb; 24(2):307-14. PubMed ID: 9972880
[TBL] [Abstract][Full Text] [Related]
25. Determination of saposin proteins (sphingolipid activator proteins) in human tissues.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Anal Biochem; 1990 Nov; 190(2):154-7. PubMed ID: 2127157
[TBL] [Abstract][Full Text] [Related]
26. Sphingolipid hydrolase activator proteins and their precursors.
Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K
Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686
[TBL] [Abstract][Full Text] [Related]
27. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
[TBL] [Abstract][Full Text] [Related]
28. Structural requirements for lysosomal targeting of the prosaposin precursor protein.
Ham D
Cell Biol Int; 2003; 27(8):675-87. PubMed ID: 12867159
[TBL] [Abstract][Full Text] [Related]
29. Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient.
Ito K; Takahashi N; Takahashi A; Shimada I; Arata Y; O'Brien JS; Kishimoto Y
Eur J Biochem; 1993 Jul; 215(1):171-9. PubMed ID: 8344278
[TBL] [Abstract][Full Text] [Related]
30. Stable Picodisc Assemblies from Saposin Proteins and Branched Detergents.
Kurgan KW; Chen B; Brown KA; Falco Cobra P; Ye X; Ge Y; Gellman SH
Biochemistry; 2021 Apr; 60(14):1108-1119. PubMed ID: 33755420
[TBL] [Abstract][Full Text] [Related]
31. Saposins (sap) A and C activate the degradation of galactosylceramide in living cells.
Harzer K; Paton BC; Christomanou H; Chatelut M; Levade T; Hiraiwa M; O'Brien JS
FEBS Lett; 1997 Nov; 417(3):270-4. PubMed ID: 9409731
[TBL] [Abstract][Full Text] [Related]
32. Expression, purification, crystallization, and preliminary X-ray analysis of recombinant human saposin B.
Ahn VE; Faull KF; Whitelegge JP; Higginson J; Fluharty AL; Privé GG
Protein Expr Purif; 2003 Jan; 27(1):186-93. PubMed ID: 12510003
[TBL] [Abstract][Full Text] [Related]
33. pH-dependent conformational properties of saposins and their interactions with phospholipid membranes.
Vaccaro AM; Ciaffoni F; Tatti M; Salvioli R; Barca A; Tognozzi D; Scerch C
J Biol Chem; 1995 Dec; 270(51):30576-80. PubMed ID: 8530492
[TBL] [Abstract][Full Text] [Related]
34. Differential membrane interactions of saposins A and C: implications for the functional specificity.
Qi X; Grabowski GA
J Biol Chem; 2001 Jul; 276(29):27010-7. PubMed ID: 11356836
[TBL] [Abstract][Full Text] [Related]
35. Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D.
Ponting CP
Protein Sci; 1994 Feb; 3(2):359-61. PubMed ID: 8003971
[TBL] [Abstract][Full Text] [Related]
36. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
37. In silico insights into protein-protein interactions and folding dynamics of the saposin-like domain of Solanum tuberosum aspartic protease.
De Moura DC; Bryksa BC; Yada RY
PLoS One; 2014; 9(9):e104315. PubMed ID: 25188221
[TBL] [Abstract][Full Text] [Related]
38. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
[TBL] [Abstract][Full Text] [Related]
39. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
[TBL] [Abstract][Full Text] [Related]
40. Saposins utilize two strategies for lipid transfer and CD1 antigen presentation.
León L; Tatituri RV; Grenha R; Sun Y; Barral DC; Minnaard AJ; Bhowruth V; Veerapen N; Besra GS; Kasmar A; Peng W; Moody DB; Grabowski GA; Brenner MB
Proc Natl Acad Sci U S A; 2012 Mar; 109(12):4357-64. PubMed ID: 22331868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
